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Abstract
Background: Further investigation of confirmed UTI in children aims to prevent renal scarring
and future complications.
Methods: We conducted a systematic review to determine the most effective approach to the
further investigation of confirmed urinary tract infection (UTI) in children under five years of age.
Results: 73 studies were included. Many studies had methodological limitations or were poorly
reported.
Effectiveness of further investigations: One study found that routine imaging did not lead to a
reduction in recurrent UTIs or renal scarring.
Diagnostic accuracy: The studies do not support the use of less invasive tests such as ultrasound as
an alternative to renal scintigraphy, either to rule out infection of the upper urinary tract (LR- =
0.57, 95%CI: 0.47, 0.68) and thus to exclude patients from further investigation or to detect renal
scarring (LR+ = 3.5, 95% CI: 2.5, 4.8). None of the tests investigated can accurately predict the
development of renal scarring. The available evidence supports the consideration of contrast-
enhanced ultrasound techniques for detecting vesico-ureteric reflux (VUR), as an alternative to
micturating cystourethrography (MCUG) (LR+ = 14.1, 95% CI: 9.5, 20.8; LR- = 0.20, 95%CI: 0.13,
0.29); these techniques have the advantage of not requiring exposure to ionising radiation.
Conclusion: There is no evidence to support the clinical effectiveness of routine investigation of
children with confirmed UTI. Primary research on the effectiveness, in terms of improved patient
outcome, of testing at all stages in the investigation of confirmed urinary tract infection is urgently
required.
Background
UTI in children is an important clinical problem. Renal
scarring, which occurs in a small proportion of children
(approximately 6%[1]), is the most important outcome of
infection as it is associated with significant future compli-
cations[2], and ultimately with end stage renal disease[3].
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renal scarring and its consequences[4]. However, a
recently completed 20-year follow-up study suggested
that compensatory mechanisms mean no significant
changes in overall GFR occur in patients with unilateral
scaring[1], and the risk of hypertension is low in all
patients (regardless of the degree of scarring)[5].
Current UK recommendations state that all children
under 5 years of age should be investigated after their first
confirmed UTI[6,7], although the benefit from this strat-
egy has been questioned[8].
Further investigation of children with confirmed UTI has
a number of different clinical aims: the localisation of
infection, the prediction and detection of renal scarring
and the detection of VUR. The current reference standards
for these investigations are Tc-99 m-DMSA renal scintigra-
phy (DMSA scan) for the localisation of infection and for
the detection and prediction of renal scarring, and mictur-
ating cystourethrography (MCUG) for the detection of
VUR. These investigations have the disadvantages of being
invasive and involving exposure to ionising radiation. It is
desirable to minimise the number of invasive examina-
tions and radiation load to which children are exposed.
Alternative tests that offer a potential advantage over the
current reference standards, such as ultrasound or labora-
tory-based tests, are therefore required. An additional aim
of the investigation of children with UTI is the detection
of anatomical abnormalities that may be amenable to sur-
gery, and a role has been suggested for ultrasound in this
context. We did not identify any studies evaluating tests
with this objective; therefore it could not be assessed in
this review. However, a recently published observational
study has suggested that routine ultrasound post-UTI, in
children under five years, does not change manage-
ment[9]. The role of pre-natal ultrasound is unclear[9,10]
and was outside the scope of this review.
We reviewed the diagnostic accuracy of tests evaluated for
the further investigation of UTI together with evidence of
their long-term effectiveness, with a view to determining
the optimum diagnostic pathway. A previous systematic
review has evaluated ultrasound for the detection of scar-
ring[11]. This review was published in 1999 with searches
undertaken in 1997 and only included 10 studies. We are
unaware of any other systematic reviews in this area. This
review therefore represents the most complete review of
the area.
Methods
We assembled a database of published and unpublished
literature from systematic searches of 16 electronic data-
bases (inception to between October 2002 and February
2003), hand searching of 12 journals, consultation with
experts in the field, and screening bibliographies of
included studies. Update searches were conducted in May
2004. There were no language restrictions. Full details of
the search strategy will be reported elsewhere[12].
We included controlled trials that compared different
imaging strategies and reported patient based outcomes.
We also included diagnostic cohort studies that included
at least 20 children, some of whom were aged five years or
under, and that reported sufficient information to con-
struct 2 × 2 tables. Table 1 presents a summary of the tests
evaluated in this review and details the potential advan-
tages that these tests have over the current reference stand-
ards. Although other tests have been evaluated, this article
will focus on those offering potential advantages over the
current reference standard. Studies had to compare one of
the index tests listed in this table to the listed reference
standard, for each of the different aims.
Two reviewers independently screened titles and abstracts
for relevance, any disagreements were resolved by consen-
sus. One reviewer performed inclusion assessment, data
extraction and quality assessment; a second reviewer
checked this. We extracted 2 × 2 data from each of the
studies and used this to calculate estimates of test per-
formance. Where insufficient details were reported, we
contacted authors to request further information. We
assessed the methodological quality of diagnostic accu-
racy studies using QUADAS[13]. Individual QUADAS
items were used to investigate heterogeneity and to
present a detailed assessment of quality to the reader.
We analysed results grouped by clinical aim. Where stud-
ies presented more than one estimate of test performance
for the same test, we only included one estimate in the
pooled analysis. We aimed to select the most appropriate
data set or the one most similar to that used by other stud-
ies in terms of population, technique or unit of analysis.
For example, data for tests used to localise infection were
analysed by patient in preference to kidney or renal unit
(kidney and ureter), whereas data for tests used to detect
VUR were analysed by renal unit. For each test, or test
combination, we calculated the range in sensitivity, specif-
icity, positive (LR+) and negative (LR-) likelihood ratios,
and diagnostic odds ratios (DOR). Where sufficient stud-
ies were available, pooled likelihood ratios were calcu-
lated for each test[14]. Heterogeneity of likelihood ratios
was investigated using the Q statistic[15] and through vis-
ual examination of forest plots of study results[16]. We
presented individual studies results graphically by plot-
ting estimates of sensitivity and specificity in receiver
operating characteristic (ROC) space. Where sufficient
data were available, we used regression analysis to investi-
gate heterogeneity. We extended the summary ROC
(sROC) model[17], estimated by regressing D (log DOR)Page 2 of 10
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weighted according to sample size, to include the varia-
bles for patient age (<2 years, <5 years, <12 years and <18
years), geographic region, and QUADAS items[18]. For
ultrasound for the detection of VUR a variable for ultra-
sound technique (contrast-enhanced or standard) was
also included.
Results
We identified more than 10,000 studies. Of these, 73
studies met our inclusion criteria: 72 diagnostic accuracy
studies and one RCT of the clinical effectiveness of inves-
tigation. Figure 1 shows the flow of studies through the
review process. The results of individual included studies
are presented [see Additional file 1]. Table 2 presents sum-
mary results for each included test.
Clinical effectiveness
One RCT evaluated the effectiveness of routine follow-up
investigation for children with confirmed UTI. This study
was published as an abstract and we are unable to obtain
further data[19].
The objective was to determine whether routine imaging,
using ultrasound and MCUG, of children with their first
UTI significantly reduced renal scarring or recurrent UTI.
Children aged 2–10 years (n = 172), with confirmed UTI,
were allocated to routine (all received Ultrasound and
MCUG) or selected imaging (Ultrasound and MCUG for
recurrent UTI or persistent problems). Routine investiga-
tion lead to higher rates of imaging (100% vs 21%), iden-
tification of VUR, and antibiotic prophylaxis compared to
the selective investigation group. However, there was no
difference in the proportion of children with recurrent
UTI or in the rate of renal scarring between the two groups
after two years of follow-up. The authors concluded that
routine imaging of toilet trained pre-school and school
aged children with their first uncomplicated UTI is not
worthwhile.
Diagnostic accuracy
None of the studies fulfilled all QUADAS criteria. Inade-
quate reporting was a problem in many studies; only two
studies reported sufficient information to determine
whether each criterion had been met. Less than half of
studies included an appropriate spectrum of patients, and
reported selection criteria. Incorporation bias, verification
bias, and disease progression bias were also inadequately
addressed by around half of all studies. Results of the
quality assessment are presented [see Additional file 2].
Localisation of infection
A total of 31 studies (61 evaluations) evaluated the diag-
nostic accuracy of one or more tests to localise infection.
Ultrasound was evaluated in 20 studies [20-39]. Perform-
ance was poor both in terms of ruling in and ruling out
renal involvement: the pooled positive likelihood ratio
was 3.5 (95% CI: 2.5, 4.8), and the pooled negative like-
lihood ratio was 0.57 (95% CI: 0.47, 0.68). Figure 2
shows estimates of sensitivity and specificity for these
Table 1: Summary of tests used for different clinical applications
Aim Current Reference standard Tests Advantage over the reference 
standard
Localisation of infection Tc-99 m-DMSA renal scintigraphy Clinical features
Laboratory-based tests
Ultrasound
All less invasive, no exposure to 
ionising radiation
Detection of reflux Micturating cystourethrography 
(MCUG)
Ultrasound Less invasive, no exposure to 
ionising radiation
Indirect radionuclide cystography Single procedure test for reflux 
and scarring
Prediction of renal scarring Follow-up Tc-99 m-DMSA renal 
scintigraphy
Clinical features Would allow earlier prediction of 
children at risk of renal scarring
Ultrasound
MCUG
Acute DMSA renal scintigraphy
Detection of renal scarring Tc-99 m-DMSA renal scintigraphy Ultrasound Less invasive, no exposure to 
ionising radiation
Intravenous pyelography (IVP) Provides a detailed anatomic map, 
considered essential where 
surgery is planned.
Radionuclide cystography Advocated as a single procedure 
test for reflux and scarringPage 3 of 10
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between study heterogeneity in the ultrasound evalua-
tions (p < 0.0001). None of the items investigated in the
regression analysis showed a significant association with
the DOR. Thirteen studies investigated clinical or
laboratory-based tests[22,25,40-50]. The tests investi-
Flow of studies through the reviewigure 1
Flow of studies through the review
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performance.
Detection of VUR
We identified 30 studies (40 evaluations) evaluating the
diagnostic accuracy of tests to detect VUR. Ultrasound was
assessed in 28 studies, 12 using standard ultrasound
techniques[35,51-61], and 16 using cystosonography or
other contrast-enhanced techniques [62-77]. Standard
ultrasound techniques performed poorly: the pooled pos-
itive LR was 1.9 (95% CI: 1.2, 2.9), and the pooled nega-
tive LR was 0.76 (95% CI: 0.63, 0.93) Contrast-enhanced
ultrasound techniques showed much better performance,
with higher pooled positive likelihood ratios (14.1, 95%
CI: 9.5, 20.8) and lower pooled negative likelihood ratios
(0.20, 95% CI: 0.13, 0.29). Figure 3 shows estimates of
sensitivity and specificity for all ultrasound studies plotted
in ROC space. Both techniques showed between study
heterogeneity (p < 0.001). Regression analysis found that
ultrasound technique, disease progression bias and use of
an appropriate reference standard showed a significant
association with the DOR. The DOR was 16.87 times
greater (95% CI: 7.03, 40.48) in studies that used contrast
enhanced ultrasound rather than standard ultrasound;
2.65 (95% CI: 1.02, 6.90) times higher in studies in which
there was no clinically significant delay between the index
test and reference standard; and 7.14 (95% CI: 1.13, 50)
times higher in studies that used an inappropriate refer-
ence standard.
Two studies evaluated indirect radionuclide voiding
cystography[78,79]. These reported good positive likeli-
hood ratios (11.2 and 25.0), but negative likelihood
ratios were poor (0.41 and 0.68).
Prediction of renal scarring
Five studies (nine evaluations) investigated the ability of
a variety of tests (clinical, laboratory-based, and imaging
techniques) to predict renal scarring[29,32,80,81]. The
diagnostic accuracies reported in these studies were poor.
Positive LRs were in the range of 1.1–3.1 for four of the
studies, with the fifth (the only study of IVP) reporting a
Table 2: Summary of the results of imaging studies
Test Number studies Range LR+ Pooled LR+ (95% CI) Range LR- Pooled LR- (95% CI)
Localisation of infection
Ultrasound 20 1.6 to 55.0 3.5 (2.5, 4.8) 0.10 to 0.91 0.57 (0.47, 0.68)
Clinical features 5 1.1 to 26.6 - 0.09 to 0.89 -
Infection markers 10 1.0 to 8.8 - 0.09 to 1.00 -
Renal function markers 4 0.7 to 36.7 - 0.02 to 1.51 -
Immunofluorescence detection of bacteria 1 1.8 - 0.55
Detection of reflux
Ultrasound: standard 12 1.0 to 8.7 1.9 (1.2, 2.9) 0.05 to 0.98 0.76 (0.63, 0.93)
Ultrasound: contrast enhanced 16 3.8 to 71.2 14.1 (9.5, 20.8) 0.04 to 0.51 0.20 (0.13, 0.29)
Indirect radionuclide cystography 3 11.2 and 25.0 - 0.41 and 0.68 -
Prediction of renal scarring
Ultrasound 2 1.3 to 3.0 - 0.60 to 0.86 -
Micturation cystourethrography 2 2.6 and 2.7 - 0.71 and 0.64 -
Temperature 1 1.1 - 0.44 -
CRP 1 1.1 - 0.44 -
Intravenous pyelography 1 12.9 - 0.88 -
Acute renal scintigraphy 1 3.1 - 0.54 -
Detection of renal scarring
Ultrasound 7 1.3 to 35.9 - 0.14 to 0.99
Intravenous pyelography 4 10 to 171.3 - 0.15 to 0.80 -
Indirect radionuclide cystography 2 2.1 to 12.6 - 0.15 to 0.75 -Page 5 of 10
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from 0.44 and 0.88.
Detection of renal scarring
Thirteen studies evaluated the diagnostic accuracy of tests
to detect renal scarring. Four studies evaluated the diag-
nostic accuracy of IVP: positive likelihood ratios were high
(10.0 to 171.3), but corresponding negative likelihood
ratios were poor (0.15 to 0.80)[80,82-84]. Only one study
included an appropriate patient spectrum[80], and this
reported a much lower positive likelihood ratio (10.0
compared to next lowest of 58.8), and higher negative
likelihood ratio (0.80 compared to next highest of 0.42)
than the others. Seven studies evaluated standard ultra-
sound techniques[60,85-90]. Figure 4 shows estimates of
sensitivity and specificity for these studies plotted in ROC
space. Performance characteristics varied greatly, although
positive likelihood ratios were generally moderate to high
(1.3–35.9). Negative likelihood ratios showed poorer
performance for ruling out scarring (0.14–0.99). Three
studies assessed the diagnostic accuracy of indirect radio-
nuclide cystography[78,84,91]; positive likelihood ratios
were moderate and ranged from 3.3 to 12.6, and negative
likelihood ratios ranged from 0.15 to 0.63.
Discussion
When considering further testing following confirmation
of UTI, it is important to bear in mind clinical aim. If the
information derived cannot be used to prevent renal dis-
ease there is little benefit in testing. Tests should only be
conducted if (a) the results will lead to a change in man-
agement and (b) this change is likely to lead to an
improved outcome. For this reason, the ideal study would
be a randomised controlled trial of different testing strat-
egies, or no testing. We identified only one such study,
and this was only available as an abstract reporting lim-
ited information, and we were unsuccessful in obtaining
further details[19]. Our results are therefore primarily
derived from diagnostic accuracy studies, which assume
the validity of the clinical aims of current testing.
Localisation of infection can be considered a first step in
the investigation of UTI. Lower UTI does not involve the
kidneys and so cannot lead to renal scarring. Children
with lower UTI are therefore unlikely to benefit from
immediate investigation. Given that therapeutic delay is
thought to be associated with renal damage[92], the pos-
sibility that they may benefit from monitoring for recur-
rence remains open to question. The ideal test to localise
infection would be non-invasive, inexpensive, and quick
to perform. Further investigation of children with
infections of the lower urinary tract could thus be
avoided. Our results do not support the use of any of the
minimally invasive tests evaluated as alternatives to renal
scintigraphy for the localisation of infection. However,
the available evidence was limited, and further primary
research in this area would be useful. Testing with the spe-
cific aim of localisation of infection is not common in
current practice. Baseline renal scintigraphy in all children
Sensitivity and specificity plotted in ROC space for ultra-sound for the localisat on of infectionFigure 2
Sensitivity and specificity plotted in ROC space for ultra-
sound for the localisation of infection
Sensitivity and specificity plotted in ROC space for ultra-sound for the detect on of refluxFigure 3
Sensitivity and specificity plotted in ROC space for ultra-
sound for the detection of reflux
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planned, may be beneficial. This approach would elimi-
nate a substantial proportion of children from further
invasive investigations.
The detection of VUR has historically been considered an
important element in the investigation of UTI, as it has
been thought to indicate an increased risk of scarring. This
idea is currently the subject of considerable debate. The
only study of the effectiveness of imaging identified by
our review compared routine and selective imaging, using
US and MCUG for the detection of VUR[19]. This study
found increased rates of VUR detection and prophylaxis
with routine imaging, but no reduction in scarring or
recurrent UTIs. Other studies have shown that the pres-
ence of VUR, as determined by MCUG, correlates poorly
with the presence of renal scarring[78,93-95]. A recent sys-
tematic review also found that VUR is a weak predictor for
renal damage in children hospitalised with UTI[96]. The
management of VUR and how this impacts on the risk of
future renal disease is also the subject of debate. A clinical
trial comparing surgical and medical management found
no difference in outcome[97], and a systematic review
evaluating antimicrobial prophylaxis for the prevention
of UTI in children found a lack of data for children with
VUR[98]. Given the considerable doubts surrounding
both the link between VUR and renal scarring, and the
benefits to be derived from treating VUR, it appears diffi-
cult to justify the routine use of MCUG. This is an inva-
sive, and costly test, involving considerable exposure to
ionising radiation; its use should therefore be minimised
where possible. Should the evaluation of VUR be consid-
ered clinically necessary, the available evidence supports
the use of contrast-enhanced ultrasound techniques as an
accurate alternative. Although not currently in widespread
use in the UK, these techniques have the advantage of not
involving exposure to ionising radiation. In addition,
standard ultrasound forms part of the examination, allow-
ing simultaneous screening for anatomical abnormalities
and some types of calculi.
A test predicting risk of renal scarring would be useful
were a treatment available to prevent its development.
Anti-microbial therapy is usually initiated in children
with confirmed UTI prior to investigation, as there is some
evidence that treatment delay may affect scarring[3,7].
Predicting risk of renal scarring as a result of a current
infection would, therefore, appear to be of academic inter-
est alone. We identified no acute tests that were able to
accurately predict the development of renal scarring. The
prediction of risk of future infection is of potential interest
in guiding the initiation of prophylactic antimicrobial
therapy, but is outside the scope of this paper.
Although the presence of renal scarring represents the ini-
tial stages of renal disease, there is little that can be done
to treat patients with scarring in order to prevent compli-
cations. If progressive scarring is assumed to be the conse-
quence of repeat infections then anti-microbial
prophylaxis may be initiated, although the effectiveness of
this strategy remains open to debate. Imaging for the
detection of renal scarring may be seen as a means of
monitoring disease progression. If repeat examination is
required then a less invasive alternative to the reference
standard (renal scintigraphy), and one which avoids the
use of ionising radiation, would seem particularly desira-
ble. We found standard ultrasound examination to be a
potentially useful test for ruling in scarring, but poor for
ruling it out. This fits with anecdotal opinion that
ultrasound is good at identifying gross scarring, but poor
at detecting minor lesions. It may be that ultrasound
images are insufficiently subtle to enable their use in
monitoring disease progression. Further research on the
accuracy of ultrasound in grading scarring is therefore
required. Indirect radionuclide cystography is sometimes
advocated as an alternative test for renal scarring, on the
grounds that it may combine detection of VUR and scar-
ring in a single test. We found it to be an accurate test for
scarring, but poor for ruling out VUR.
Conclusion
There is no evidence to support the clinical effectiveness of
routine investigation of children with confirmed UTI.
There is limited evidence that routine imaging to detect
Sensitivity and specificity plotted in ROC space for ultra-sound for the detect on of scarringFigure 4
Sensitivity and specificity plotted in ROC space for ultra-
sound for the detection of scarringPage 7 of 10
(page number not for citation purposes)
BMC Pediatrics 2005, 5:2 http://www.biomedcentral.com/1471-2431/5/2VUR, following first UTI in older children, has no effect on
recurrence or renal scarring.
High quality primary research on the effectiveness, in
terms of improved patient outcome, of testing at all stages
in the investigation of confirmed UTI is urgently required.
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